Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Wake Forest University Health Sciences
Young Adult Survivors United
St. Jude Children's Research Hospital
Peking Union Medical College Hospital
University of Virginia
Catalysis SL
Seattle Children's Hospital
UNICANCER
Deciphera Pharmaceuticals, LLC
West China Hospital
National University of Singapore
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ann & Robert H Lurie Children's Hospital of Chicago